Ginkgo Bioworks Holdings, Inc.

Biotechnology company · Boston, Massachusetts, United States · NYSE: DNA

Ginkgo Bioworks Holdings, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its shares trade on NYSE under the ticker DNA.

Profile compiled from public records. Is this your company? Request a correction or update

Ginkgo Bioworks Holdings at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Stock listingNYSE: DNA

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1830214

Frequently asked questions about Ginkgo Bioworks Holdings

Where is Ginkgo Bioworks Holdings headquartered?

Ginkgo Bioworks Holdings, Inc. is headquartered in Boston, Massachusetts, United States.

What does Ginkgo Bioworks Holdings do?

Ginkgo Bioworks Holdings, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Ginkgo Bioworks Holdings a public company?

Yes. Ginkgo Bioworks Holdings, Inc. trades on NYSE under the ticker DNA.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences